Grantham, Mayo, Van Otterloo & Co (GMO)’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.25M | Buy |
61,585
+23,968
| +64% | +$1.65M | 0.01% | 311 |
|
|
2025
Q1 | $2.61M | Buy |
+37,617
| New | +$2.61M | 0.01% | 359 |
|
|
2019
Q3 | – | Sell |
-733,180
| Closed | -$37.4M | – | 770 |
|
|
2019
Q2 | $37.4M | Sell |
733,180
-443,600
| -38% | -$22.6M | 0.26% | 67 |
|
|
2019
Q1 | $61.6M | Buy |
1,176,780
+175,800
| +18% | +$9.2M | 0.44% | 48 |
|
|
2018
Q4 | $46.1M | Buy |
1,000,980
+17,100
| +2% | +$788K | 0.37% | 54 |
|
|
2018
Q3 | $46.4M | Buy |
983,880
+302,353
| +44% | +$14.3M | 0.31% | 62 |
|
|
2018
Q2 | $31.4M | Buy |
681,527
+24,527
| +4% | +$1.13M | 0.22% | 68 |
|
|
2018
Q1 | $32.4M | Buy |
+657,000
| New | +$32.4M | 0.2% | 82 |
|
|
2016
Q4 | – | Sell |
-61,700
| Closed | -$2.57M | – | 507 |
|
|
2016
Q3 | $2.57M | Sell |
61,700
-25,900
| -30% | -$1.08M | 0.01% | 290 |
|
|
2016
Q2 | $4.71M | Sell |
87,600
-35,000
| -29% | -$1.88M | 0.02% | 290 |
|
|
2016
Q1 | $6.64M | Buy |
+122,600
| New | +$6.64M | 0.02% | 274 |
|